New Treatment Options for Multiple Myeloma Improves Patients’ Overall Survival, Quality of Life
Multiple myeloma (MM) is a form of cancer where abnormal plasma cells, a type of white blood cell, accumulate in the bone marrow and replace the normal, healthy cells. While healthy plasma cells produce antibodies, cancerous plasma cells produce abnormal proteins, and the by-products of these proteins cause complications. New treatment options have transformed MM from an acute disease with a median survival of <6 months to a chronic condition where patients have better survival and quality of life (QOL).
Color 1
Color 2
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in